Hou Xiaorong, Li Wanzhen, Liu Pan, Liu Zhen, Yuan Yanchun, Ni Jie, Shen Lu, Tang Beisha, Wang Junling
Department of Neurology, Xiangya Hospital, Central South University, Changsha, China.
National Clinical Research Center for Geriatric Diseases, Xiangya Hospital, Central South University, Changsha, China.
Front Neurol. 2022 May 6;13:811202. doi: 10.3389/fneur.2022.811202. eCollection 2022.
Repeat expansions, including those in and , have been implicated in amyotrophic lateral sclerosis (ALS). However, there have been few studies on the association of and repeat expansion with ALS, especially in China. Accordingly, we aimed to evaluate the frequency of and repeat mutations and investigate whether and repeat expansion are risk factors for ALS.
In this study, 736 ALS patients and several hundred healthy controls were recruited. Polymerase chain reaction (PCR) and repeat-primed PCR (RP-PCR) were performed to determine the repeat lengths in , and .
GGGGCC repeats in were observed in six ALS patients (0.8%, 6/736) but not in any of the controls (0/365). The patients with pathogenic GGGGCC repeats showed shorter median survival times than those with a normal genotype ( = 0.006). Regarding CAG repeats, we identified that intermediate repeat lengths (29-34 copies) were associated with ALS ( = 0.033), and there was no difference in clinical characteristics between the groups with and without intermediate repeats ( > 0.05). Meanwhile, we observed that there was no association between the repeat size in and and ALS ( > 0.05).
Our results demonstrated that pathogenetic repeats in are rare in China, while intermediate CAG repeats in are more frequent but have no effect on disease phenotypes; the repeat size in and may not be a risk factor for ALS.
重复序列扩增,包括在[具体基因1]和[具体基因2]中的扩增,已被认为与肌萎缩侧索硬化症(ALS)有关。然而,关于[具体基因1]和[具体基因2]重复序列扩增与ALS的关联研究较少,尤其是在中国。因此,我们旨在评估[具体基因1]和[具体基因2]重复突变的频率,并调查[具体基因1]和[具体基因2]重复序列扩增是否为ALS的危险因素。
在本研究中,招募了736例ALS患者和数百名健康对照。采用聚合酶链反应(PCR)和重复引物PCR(RP-PCR)来确定[具体基因1]和[具体基因2]中的重复长度。
在6例ALS患者(0.8%,6/736)中观察到[具体基因1]中的GGGGCC重复序列,但在任何对照中均未观察到(0/365)。具有致病性GGGGCC重复序列的患者中位生存时间短于基因型正常的患者(P = 0.006)。关于[具体基因2]的CAG重复序列,我们发现中等重复长度(29 - 34个拷贝)与ALS相关(P = 0.033),并且有中等重复序列和无中等重复序列的组之间临床特征无差异(P>0.05)。同时,我们观察到[具体基因1]和[具体基因2]中的重复大小与ALS之间无关联(P>0.05)。
我们的结果表明,在中国[具体基因1]中的致病性重复序列罕见,而[具体基因2]中的中等CAG重复序列更常见但对疾病表型无影响;[具体基因1]和[具体基因2]中的重复大小可能不是ALS的危险因素。